About this journal
Aims and scope
Adipocyte is a fully open access, multi-disciplinary journal that publishes research on all aspects of adipose tissue physiology and pathophysiology.
Recognising the dynamic role of the adipose tissue and its contribution to a variety of physiological and pathological processes, Adipocyte accepts manuscripts that use basic, translational, or clinical approaches to explore the link between dysfunctional adipose tissue and a growing number of chronic diseases (including, but not limited to, diabetes, hypertension, cardiovascular disease and cancer)
Specific topics covered include:
- Adipose tissue structure and development
- Adipogenesis, adipose stem cells
- Adipose inflammation, immune cells
- Insulin resistance and diabetes
- Metabolism and energy balance
- Mitochondrial dysfunction
- Adipose hypoxia, apoptosis
- Adipokines and angiogenesis
- Cardiovascular disease, vascular homeostasis, and hypertension
- Thermogenesis and lipids, fatty acids, or brown/beige fat
- Reproduction, obesity and cancer
- Diabetes and obesity
- Systems Biology and Bioinformatics
- Adipocyte biology relating to plastic/reconstructive surgery
- Adipocyte biology relating to dermatology
Adipocyte accepts high-profile submissions in basic, translational and clinical research.
Please note that this journal only publishes manuscripts in English.
The journal operates a single-anonymized peer review policy.
All articles are made freely and permanently available online through gold open access publication.
Journal metrics
Usage
- 215K annual downloads/views
Citation metrics
- 3.5 (2023) Impact Factor
- Q2 Impact Factor Best Quartile
- 3.6 (2023) 5 year IF
- 6.5 (2023) CiteScore (Scopus)
- Q1 CiteScore Best Quartile
- 0.833 (2023) SNIP
- 0.960 (2023) SJR
Speed/acceptance
- 28 days avg. from submission to first decision
- 48% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Fahumiya Samad - San Diego Biomedical Research Institute, USA
Associate Editor
Tae-Hwa Chun - University of Michigan, Ann Arbor, MI, USA
Jaap G. Neels - INSERM, Nice, France
Acquisitions Editor
Azaam M. Samad - Dr, San Diego Biomedical Research Institute, USA
Editorial Board
Nada Abumrad - Washington University in St Louis, St Louis, MO, USA
Colin Adrain - Queen's University Belfast, Belfast, UK
David B. Allison - University of Alabama at Birmingham, Birmingham, AB, USA
Alessandro Bartolomucci - University of Minnesota, Minneapolis, MN, USA
Barbara Cannon - Stockholm University, Stockholm, Sweden
Lisa A. Cassis - University of Kentucky, Lexington, KY, USA
Xiaoli Chen - University of Minnesota, Minneapolis, MN, USA
Theodore P. Ciaraldi - UCSD, San Diego, CA, USA
Lily Q. Dong - UT Health Science Center, San Antonio, TX, USA
Michelle T. Foster - Colorado State University, Fort Collins, CO, USA
Mark Horowitz - Yale University, New Haven, CT, USA
Gökhan S. Hotamisligil - Harvard University School of Public Health, Cambridge, MA, USA
Jasper de Jong - Yale School of Medicine, New Haven, CT, USA
Zhen Y. Jiang - Sanford Burnham Prebys , La Jolla, CA, USA
Jasper de Jong - Yale School of Medicine, New Haven, CT, USA
Dwight J. Klemm - University of Colorado School of Medicine, Fort Collins, CO, USA
Mikhail Kolonin - University of Texas Health Science Centre, Houston, TX, USA
Daniel Konrad - University of Zurich, Zurich, Switerland
Shihuan Kuang - Purdue University, West Lafayette, IN, USA
Daniel A. Lawrence - University of Michigan, Ann Arbor, MI, USA
Chih-Hao Lee - Harvard University School of Public Health, Cambridge, MA, USA
Kyongbum Lee - Tufts University, Medford, MA, USA
Jongsoon Lee - Joslin Diabetes Center, Boston, MA, USA
Jun Liu - Mayo Clinic College of Medicine and Science, Rochester, MN, USA
Simin Liu - Brown University, Providence, RI, USA
Ormond A. MacDougald - University of Michigan, Ann Arbor, MI, USA
Rebecca Martin - Virginia Commonwealth University, Richmond, VA, USA
Elisabette Mueller - NYU Grossman School of Medicine, New York City, NY, USA
Christian Meyer - Translational Research Institute for Metabolism & Diabetes, Orlando, FL, USA
Marthe Moldes - INSERM/Sorbonne University, Paris, France
Vipul Periwal - NIDDK, Bethesda, MD, USA
Miklos Peterfy - UCLA, Los Angeles, CA, USA
Li Qiang - Columbia University Medical Center, New York City, NY, USA
Daniel J. Rader - University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Sushil G. Rane - NIDDK, Bethesda, MD, USA
Matthew Rodeheffer - Yale University, New Haven, CT, USA
Jaswinder K. Sethi - University of Cambridge, Cambridge, UK,
Jianhua Shao - UCSD, San Diego, CA, USA
Rajat Singh - Albert Einstein College of Medicine, New York City, NY, USA
Cynthia Smas - University of Toledo College of Medicine, Toledo, OH, USA
Matthew Steinhauser - University of Pittsburgh, Pittsburgh, PA, USA
Jacqueline M. Stephens - Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA
Matthias H. Tschöp - Institute for Diabetes and Obesity, Helmholtz Zentrum München and Technische Universität München, Munich, Germany
Yu-Hua Tseng - Joslin Diabetes Center, Boston, MA, USA
Li-Na Wei - University of Minnesota, Minneapolis, MN, USA
Aimin Xu - The University of Hong Kong, Hong Kong, China,
Qin Yang - UC Irvine, Irvine, CA, USA
Patrick Yue - Stanford University School of Medicine, Stanford, USA,
Werner Zwerschke - University of Innsbruck, Innsbruck, Austria
Abstracting and indexing
Abstracted and/or Indexed in:
- DOAJ
- EMBASE
- MEDLINE
- PubMed Central
- Science Citation Index Expanded
Citing articles in the journal
Citing articles in Adipocyte should follow traditional convention.
For example:
Henrik Svensson, Louise Wetterling, Ulrika Andersson-Hall, Eva Jennische, Staffan Edén, Agneta Holmäng & Malin Lönn (2018) Adipose tissue and body composition in women six years after gestational diabetes: Factors associated with development of type 2 diabetes, Adipocyte, DOI:
Open access
Adipocyte is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
News, offers and calls for papers
Continuous publication
Advertising information
Would you like to advertise in Adipocyte?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Adipocyte.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors